RICHARD BERGERON: Open Payments
NPI 1700323540 · HOUMA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$826 in 34 payments from 10 companies in 2025. Trend: 2023 $661 · 2024 $666 · 2025 $826
Food & beverage: $826
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 7 | $362 |
| Corium, LLC | 6 | $116 |
| Supernus Pharmaceuticals, Inc. | 8 | $100 |
| Alkermes, Inc. | 4 | $71 |
| Collegium Pharmaceutical, Inc. | 2 | $39 |
| E.R. Squibb & Sons, L.L.C. | 2 | $38 |
| ABBVIE INC. | 2 | $36 |
| Abbott Laboratories | 1 | $25 |
| Lundbeck LLC | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
Products named: Auvelity, Azstarys, Qelbree, ARISTADA, Jornay PM, COBENFY, VRAYLAR, FREESTYLE LIBRE.
Industry payments across LA — which companies pay providers there.
